Subcutaneous Abatacept in Renal Transplant Recipients
NCT05975450
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Kidney Transplant Recipient
Interventions
DRUG:
Abatacept 125Mg/Ml Syringe
Sponsor
Idelberto Badell
Collaborators
[object Object]